Scalper1 News
Drugstore operators seeking new ways to boost revenue have been entering the pharmacy benefit managing field. Rite Aid (RAD) became the latest to do so, announcing Wednesday it’s buying EnvisionRx, a pharmacy benefit manager owned by private equity firm TPG, for $1.8 billion in cash and $200 million in stock. The acquisition will let Rite Aid run prescription drug plans and compete withExpress Scripts (ESRX) and CVS Health (CVS). Rite Aid shares Scalper1 News
Scalper1 News